Clinical impact of first‐line PD‐1 or PD‐L1 inhibitors combined with chemotherapy in extensive‐stage small cell lung cancer patients: A real‐world multicenter propensity score‐matched study

Abstract Objectives Our research aimed to evaluate the effectiveness of first‐line immune checkpoint inhibitors (ICIs) with etoposide and platinum (EP) for extensive‐stage small cell lung cancer (ES‐SCLC) and identify prognostic factors, as real‐world outcomes and the inconsistency of PD‐1 and PD‐L1...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Jingyuan Xie, Mo Chen, Hedong Han, Ke Xu, Guihuan Qiu, Xinqing Lin, Yong Song, Jinjun Ye, Tangfeng Lv, Ping Zhan
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Wiley 2023-05-01
Edice:	Thoracic Cancer
Témata:	extensive‐stage SCLC PD‐1 inhibitors PD‐L1 inhibitors propensity score‐matched analysis risk factors
On-line přístup:	https://doi.org/10.1111/1759-7714.14874
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!